Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
In recent years, the immune system has emerged as a critical regulator of tumor development, progression and dissemination. Advanced therapeutic approaches targeting immune cells are currently under clinical use and improvement for the treatment of patients affected by advanced malignancies. Among t...
Main Authors: | Augusto Bleve, Francesca Maria Consonni, Chiara Porta, Valentina Garlatti, Antonio Sica |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/510 |
Similar Items
-
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
by: Augusto Bleve, et al.
Published: (2020-08-01) -
Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01) -
Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion
by: Sophiya Siddiqui, et al.
Published: (2022-01-01) -
Tasquinimod targets suppressive myeloid cells in the tumor microenvironment
by: Li Shen, et al.
Published: (2019-10-01) -
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
by: Jennifer Frosch, et al.
Published: (2021-04-01)